From cognitive science to dementia assessment

Robert Logie, Mario Parra Rodriguez, Sergio Della Sala

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Alzheimer’s disease is a degenerative disease of the brain that impairs mental skills and abilities and undermines independent living. It is estimated to affect over 44 million people worldwide, and 5.3 million people in the United States at an estimated cost of US$226 billion. The numbers of people affected are expected to increase dramatically over the next few decades along with increased life expectancy, and costs are expected to be over US$1 trillion by 2050. There is currently no cure, and accurate diagnosis in primary care is hampered by a lack of widely available, reliable, and specific forms of assessment.Accurate diagnosis is essential to avoid inappropriate and expensive clinical follow-up, to evaluate new treatments when these become available, to avoid underestimating or overestimating prevalence of the disease, and to inform policy priorities on resource allocation for health care and for research. We argue that the cognitive and behavioral sciences offer an important route to developing widely available, inexpensive, reliable, and specific assessment tools for the disease.
LanguageEnglish
Pages81-91
Number of pages11
JournalBehavioral and Brain Sciences
Volume2
Issue number1
DOIs
Publication statusPublished - 1 Oct 2015

Fingerprint

Cognitive Science
Dementia
Independent Living
Behavioral Sciences
Costs and Cost Analysis
Aptitude
Resource Allocation
Health Services Research
Brain Diseases
Life Expectancy
Primary Health Care
Alzheimer Disease
Therapeutics

Keywords

  • Alzheimer’s disease
  • diagnosis of Alzheimer’s disease
  • biomarkers for Alzheimer’s disease
  • cognitive markers for Alzheimer’s disease
  • evaluating treatments for Alzheimer’s disease

Cite this

Logie, Robert ; Parra Rodriguez, Mario ; Della Sala, Sergio. / From cognitive science to dementia assessment. In: Behavioral and Brain Sciences. 2015 ; Vol. 2, No. 1. pp. 81-91.
@article{48bd32f429134c44bf1dfff3668357cc,
title = "From cognitive science to dementia assessment",
abstract = "Alzheimer’s disease is a degenerative disease of the brain that impairs mental skills and abilities and undermines independent living. It is estimated to affect over 44 million people worldwide, and 5.3 million people in the United States at an estimated cost of US$226 billion. The numbers of people affected are expected to increase dramatically over the next few decades along with increased life expectancy, and costs are expected to be over US$1 trillion by 2050. There is currently no cure, and accurate diagnosis in primary care is hampered by a lack of widely available, reliable, and specific forms of assessment.Accurate diagnosis is essential to avoid inappropriate and expensive clinical follow-up, to evaluate new treatments when these become available, to avoid underestimating or overestimating prevalence of the disease, and to inform policy priorities on resource allocation for health care and for research. We argue that the cognitive and behavioral sciences offer an important route to developing widely available, inexpensive, reliable, and specific assessment tools for the disease.",
keywords = "Alzheimer’s disease, diagnosis of Alzheimer’s disease, biomarkers for Alzheimer’s disease, cognitive markers for Alzheimer’s disease, evaluating treatments for Alzheimer’s disease",
author = "Robert Logie and {Parra Rodriguez}, Mario and {Della Sala}, Sergio",
year = "2015",
month = "10",
day = "1",
doi = "10.1177/2372732215601370",
language = "English",
volume = "2",
pages = "81--91",
journal = "Behavioral and Brain Sciences",
issn = "0140-525X",
publisher = "Cambridge University Press",
number = "1",

}

From cognitive science to dementia assessment. / Logie, Robert; Parra Rodriguez, Mario; Della Sala, Sergio.

In: Behavioral and Brain Sciences, Vol. 2, No. 1, 01.10.2015, p. 81-91.

Research output: Contribution to journalArticle

TY - JOUR

T1 - From cognitive science to dementia assessment

AU - Logie, Robert

AU - Parra Rodriguez, Mario

AU - Della Sala, Sergio

PY - 2015/10/1

Y1 - 2015/10/1

N2 - Alzheimer’s disease is a degenerative disease of the brain that impairs mental skills and abilities and undermines independent living. It is estimated to affect over 44 million people worldwide, and 5.3 million people in the United States at an estimated cost of US$226 billion. The numbers of people affected are expected to increase dramatically over the next few decades along with increased life expectancy, and costs are expected to be over US$1 trillion by 2050. There is currently no cure, and accurate diagnosis in primary care is hampered by a lack of widely available, reliable, and specific forms of assessment.Accurate diagnosis is essential to avoid inappropriate and expensive clinical follow-up, to evaluate new treatments when these become available, to avoid underestimating or overestimating prevalence of the disease, and to inform policy priorities on resource allocation for health care and for research. We argue that the cognitive and behavioral sciences offer an important route to developing widely available, inexpensive, reliable, and specific assessment tools for the disease.

AB - Alzheimer’s disease is a degenerative disease of the brain that impairs mental skills and abilities and undermines independent living. It is estimated to affect over 44 million people worldwide, and 5.3 million people in the United States at an estimated cost of US$226 billion. The numbers of people affected are expected to increase dramatically over the next few decades along with increased life expectancy, and costs are expected to be over US$1 trillion by 2050. There is currently no cure, and accurate diagnosis in primary care is hampered by a lack of widely available, reliable, and specific forms of assessment.Accurate diagnosis is essential to avoid inappropriate and expensive clinical follow-up, to evaluate new treatments when these become available, to avoid underestimating or overestimating prevalence of the disease, and to inform policy priorities on resource allocation for health care and for research. We argue that the cognitive and behavioral sciences offer an important route to developing widely available, inexpensive, reliable, and specific assessment tools for the disease.

KW - Alzheimer’s disease

KW - diagnosis of Alzheimer’s disease

KW - biomarkers for Alzheimer’s disease

KW - cognitive markers for Alzheimer’s disease

KW - evaluating treatments for Alzheimer’s disease

U2 - 10.1177/2372732215601370

DO - 10.1177/2372732215601370

M3 - Article

VL - 2

SP - 81

EP - 91

JO - Behavioral and Brain Sciences

T2 - Behavioral and Brain Sciences

JF - Behavioral and Brain Sciences

SN - 0140-525X

IS - 1

ER -